Publication Name	World Journal of Psychiatry
Manuscript ID	107597
Country	Türkiye

Received	2025-03-27 03:59
Peer-Review Started	2025-03-31 00:19
To Make the First Decision
Return for Revision	2025-04-03 08:46
Revised	2025-04-09 07:02
Second Decision	2025-05-19 13:46
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-05-26 10:36
Articles in Press	2025-05-26 10:36
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-05-30 06:37
Typeset the Manuscript	2025-06-21 03:15
Publish the Manuscript Online	2025-07-10 03:52

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Psychiatry
Manuscript Type	Review
Article Title	Pharmacoepigenetics in schizophrenia: Predicting drug response
Manuscript Source	Invited Manuscript
All Author List	Sariye Aybüke Yıldırım, Irmak Dal, Selin Özkan-Kotiloğlu, Bora Baskak and Dilek Kaya-Akyüzlü
Funding Agency and Grant Number
Corresponding Author	Dilek Kaya-Akyüzlü, PhD, Professor, Department of Forensic Biology, Institute of Forensic Sciences, Ankara University, Mamak, Ankara 06590, Türkiye. kayadilek79@gmail.com
Key Words	Pharmacoepigenetics; Treatment failures; Personalized medicine; Antipsychotic drugs; Schizophrenia
Core Tip	Epigenetic mechanisms play a critical role in the pathogenesis of schizophrenia and contribute to variability in treatment response. Advances in personalized medicine and epigenetic studies offer promising avenues to improve schizophrenia treatment by tailoring therapeutic strategies to individual genetic and epigenetic profiles. However, further research is needed to develop more specific and effective epigenetic therapies to overcome challenges related to treatment efficacy and duration. Integrating epigenetic data into personalized medicine approaches will ultimately improve patient outcomes and revolutionize schizophrenia management.
Publish Date	2025-07-10 03:52
Citation	<p>Yıldırım SA, Dal I, Özkan-Kotiloğlu S, Baskak B, Kaya-Akyüzlü D. Pharmacoepigenetics in schizophrenia: Predicting drug response. <i>World J Psychiatry</i> 2025; 15(7): 107597</p>
URL	https://www.wjgnet.com/2220-3206/full/v15/i7/107597.htm
DOI	https://dx.doi.org/10.5498/wjp.v15.i7.107597

Full Article (PDF)	WJP-15-107597-with-cover.pdf
Manuscript File	107597_Auto_Edited_102838.docx
Answering Reviewers	107597-answering-reviewers.pdf
Audio Core Tip	107597-audio.mp3
Conflict-of-Interest Disclosure Form	107597-conflict-of-interest-statement.pdf
Copyright License Agreement	107597-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	107597-non-native-speakers.pdf
Peer-review Report	107597-peer-reviews.pdf
Scientific Misconduct Check	107597-scientific-misconduct-check.png
Scientific Editor Work List	107597-scientific-editor-work-list.pdf
CrossCheck Report	107597-crosscheck-report.pdf